These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2464842)

  • 1. Distribution model for the intact urokinase and urokinases modified by soluble macromolecules in rat and mouse bodies.
    Jin FX; Cheng YH; Toda K
    Radioisotopes; 1988 Aug; 37(8):441-7. PubMed ID: 2464842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of human recombinant tissue-type plasminogen activator and urokinase in microsurgical thrombolysis in the rat.
    Levy EA; Sadove AM; Eppley BL; Evan AP
    J Reconstr Microsurg; 1991 Jul; 7(3):209-16. PubMed ID: 1909760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological and thrombolytic properties of proenzyme and active forms of human urokinase--II. Turnover of natural and recombinant urokinase in rabbits and squirrel monkeys.
    Collen D; De Cock F; Lijnen HR
    Thromb Haemost; 1984 Aug; 52(1):24-6. PubMed ID: 6495260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Half-life of single-chain urokinase-type plasminogen activator (scu-PA) and two-chain urokinase-type plasminogen activator (tcu-PA) in patients with acute myocardial infarction.
    Köhler M; Sen S; Miyashita C; Hermes R; Pindur G; Heiden M; Berg G; Mörsdorf S; Leipnitz G; Zeppezauer M
    Thromb Res; 1991 Apr; 62(1-2):75-81. PubMed ID: 1906642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transport of urokinase across the intestinal tract of normal human subjects with stimulation of synthesis and/or release of urokinase-type proteins.
    Toki N; Sumi H; Sasaki K; Boreisha I; Robbins KC
    J Clin Invest; 1985 Apr; 75(4):1212-22. PubMed ID: 3921568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The beneficial effect of lys-plasminogen upon the thrombolytic efficacy of urokinase in a dog model of peripheral arterial thrombosis.
    Badylak SF; Voytik SL; Henkin J; Burke S; Sasahara AA; Simmons A
    Haemostasis; 1991; 21(5):278-85. PubMed ID: 1806456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistological detection of Saruplase (recombinant single-chain urokinase-type plasminogen activator) in normal rat tissue.
    Wöhrmann T; Matthiesen T; Beier H; Flohé L
    Histochemistry; 1991; 96(2):163-7. PubMed ID: 1917573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localization of tissue plasminogen activator on experimental thrombi in rats.
    Kimata H; Nakajima K; Koide T; Yamamoto S; Kondo S
    J Pharmacobiodyn; 1990 Dec; 13(12):751-9. PubMed ID: 2129128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bolus dose response characteristics of single chain urokinase plasminogen activator and tissue plasminogen activator in a dog model of arterial thrombosis.
    Badylak SF; Voytik S; Klabunde RE; Henkin J; Leski M
    Thromb Res; 1988 Nov; 52(4):295-312. PubMed ID: 3144052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the low-density lipoprotein receptor-related protein (LRP) in the plasma clearance and liver uptake of recombinant single-chain urokinase-type plasminogen activator in rats.
    van der Kaaden ME; Rijken DC; Kruijt JK; van Berkel TJ; Kuiper J
    Thromb Haemost; 1997 Apr; 77(4):710-7. PubMed ID: 9134648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombolytic and pharmacokinetic properties of chimeric tissue-type and urokinase-type plasminogen activators.
    Collen D; Lu HR; Lijnen HR; Nelles L; Stassen JM
    Circulation; 1991 Sep; 84(3):1216-34. PubMed ID: 1909220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological and thrombolytic properties of proenzyme and active forms of human urokinase--I. Fibrinolytic and fibrinogenolytic properties in human plasma in vitro of urokinases obtained from human urine or by recombinant DNA technology.
    Zamarron C; Lijnen HR; Van Hoef B; Collen D
    Thromb Haemost; 1984 Aug; 52(1):19-23. PubMed ID: 6495259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of dextran sulfate in urokinase therapy and evaluation of the effects by estimation of plasmin inhibitor, fibrinogenolytic degradation products, and fibrinolytic degradation products.
    Hasegawa H; Nagata H; Yamauchi M; Murakoshi T; Oguma Y; Takei H; Seya T; Murao M
    Jpn Heart J; 1982 May; 23(3):339-47. PubMed ID: 6178853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of Lys- and mini-plasminogen on clot lysis induced by recombinant urokinase and recombinant pro-urokinase in a canine thrombosis model.
    Burke SE; Davidson DJ; Lubbers NL; Reininger IM; Henkin J
    Thromb Res; 1996 Sep; 83(6):421-31. PubMed ID: 8885137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasoactive intestinal polypeptide (VIP) stimulates fibrinolytic system in the rat.
    Hagiwara M; Hongo K; Morikawa T
    Jpn J Pharmacol; 1990 Sep; 54(1):86-8. PubMed ID: 2273652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled trial of combined urokinase and dextran sulfate therapy in patients with acute cerebral infarction.
    Fujishima M; Omae T; Tanaka K; Iino K; Matsuo O; Mihara H
    Angiology; 1986 Jul; 37(7):487-98. PubMed ID: 2425671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on metabolism of urokinase and mechanism of thrombolysis by urokinase.
    Ueno T; Kobayashi N; Maekawa T
    Thromb Haemost; 1979 Oct; 42(3):885-94. PubMed ID: 505403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study of the promotion of tissue plasminogen activator and pro-urokinase-induced plasminogen activation by fragments D and E-2 of fibrin.
    Liu JN; Gurewich V
    J Clin Invest; 1991 Dec; 88(6):2012-7. PubMed ID: 1836471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physicochemical characterization of PEG-PPG conjugated human urokinase.
    Kajihara J; Shibata K; Nakano Y; Nishimuro S; Kato K
    Biochim Biophys Acta; 1994 Mar; 1199(2):202-8. PubMed ID: 8123669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic studies on soluble and insoluble urokinases.
    Capet-Antonini FC; Tamenasse J
    Can J Biochem; 1975 Aug; 53(8):890-4. PubMed ID: 241473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.